Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. - Wikidata - wikimedia - TriplyDB

Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.

Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.

http://www.wikidata.org/entity/Q34708388

about

Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure Survival Benefits With Artificial Liver Support System for Acute-on-Chronic Liver Failure: A Time Series-Based Meta-Analysis Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Detoxification as a treatment goal in hepatic failure.No sustained impact of intermittent extracorporeal liver support on thrombocyte time course in a randomized controlled albumin dialysis trial.Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study Treatment of hepatic encephalopathy by on-line hemodiafiltration: a case series study.Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options.Management of hepatic encephalopathy in the hospital Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes.Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary.Current trends in the treatment of hepatic encephalopathy.Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study.Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.The end-organ impairment in liver cirrhosis: appointments for critical care.Logistic regression model can reduce unnecessary artificial liver support in hepatitis B virus-associated acute-on-chronic liver failure: decision curve analysis.Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.Covert and Overt Hepatic Encephalopathy: Diagnosis and Management First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis.Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study Hepatic encephalopathy: an updated approach from pathogenesis to treatment Bacterial infections in end-stage liver disease: current challenges and future directions The role of etiology in the hyperamylasemia of acute liver failure How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist.Extracorporeal continuous portal diversion plus temporal plasmapheresis for "small-for-size" syndrome.Survival predictors in patients treated with a molecular adsorbent recirculating system Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.Emerging drugs for hepatic encephalopathy.Treatment options for hepatic encephalopathy.Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.Extracorporeal liver support.Critical care of the end-stage liver disease patient awaiting liver transplantation.Renal replacement therapy in special settings: extracorporeal support devices in liver failure.Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions.Using albumin to improve the therapeutic properties of diabetes treatments.Albumin dialysis: current practice and future options.

P2860

Q21195009-C94EACB1-68D5-43B8-9219-E4D5988F3A88 Q26771851-04F8C038-D6E0-4C99-A09A-3E79CBCD6093 Q26773433-2EF5ADE8-81AF-44EA-94E5-B8545BFAECFE Q26778000-50E2F707-CA05-4C4A-99FF-22E686BFD54F Q30234560-464E5CD2-597C-487C-A64A-9211B058CDB7 Q33396573-19A7C075-DF81-4C4E-8F6E-DAC316B90AEC Q33417539-6681B59D-A66E-42DC-BD13-927D7D6AF982 Q33558782-94E63449-A788-4964-ADBA-B5C8D27CF3AC Q33584281-43F16CF1-1E38-4534-827B-9D527A9F621B Q33805285-E0B3BA28-ADB5-4327-998D-EA67761F18C3 Q34028149-8BF18305-8189-4B2E-B268-46893465EBF3 Q34404386-22D15B97-3F5A-4650-8015-88F045571BDC Q34503111-379D0B19-61B0-45F2-A33B-BCE3322E81E3 Q34530153-025F181D-277F-4BE2-8EE6-2AEBEC1E05E3 Q34611198-658DA412-DDFF-4CB5-B596-C6A940605483 Q34768560-7E46F808-82CA-4A58-97AF-5E5C3A41BA71 Q35642846-4204E541-38D1-48C7-9B19-1715F2259B56 Q35993701-08BEDC9B-401E-4642-B0AB-A13F29D3D4B2 Q36040654-16B7D7ED-6620-4FCF-BD45-4471B23D3D9B Q36093575-EBBE4707-48EA-4A62-A3A4-AF1C84749824 Q36199772-65E55343-29C0-48F1-93BE-E85DCDBDE3C5 Q36283332-BDC98535-4A62-4F38-89FC-57525E267FD9 Q36357186-D5ED9DBF-0CAA-4E82-A285-4D5A7410DBE4 Q36424482-073DCE5C-CE09-41A7-AA19-304F7F2AEA18 Q36473777-D79089DC-E29A-4253-ADEA-52D83B9E3074 Q36705999-7838A612-40C2-4371-9F89-A25979B385A8 Q36810928-A26DD6EA-9AAE-423E-8076-05A93373AD68 Q36947936-9A79035D-E955-4458-AC98-303A6EE9CAC0 Q37142199-536A381B-EEB7-4211-89D9-682DA4C1E0F4 Q37241955-0CFF5604-2D16-4B07-8194-706BE8DFAA46 Q37489472-99CC037A-D281-4695-AD4A-74EA2F882743 Q37529838-72F6500E-A7B4-4B7E-915B-D0FFD50233BB Q37735854-46A26BE9-D883-45E9-9F93-738BA5A2C780 Q37838478-D861F19B-3B49-4AA4-A14A-44E380727802 Q37846058-A985879F-CEE9-41EE-960A-CC46839F4E7A Q37867071-61C2A7A6-739F-4ACA-8F8F-33C1D58F54E3 Q37868691-4791CA2D-B696-46AC-903A-9C0824224792 Q37903856-E3ECC201-5D00-48E2-8D47-FE6BCFEAE13D Q37910976-3401BDCA-96E2-4C66-B85C-941C9606ACD4 Q37913530-73F81E33-C9E2-40F9-9B55-1703E749D4FC

P2860

Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.

http://www.wikidata.org/entity/Q34708388

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Randomized controlled study of ...... lopathy in advanced cirrhosis.

@ast

Randomized controlled study of ...... lopathy in advanced cirrhosis.

@en

Randomized controlled study of ...... lopathy in advanced cirrhosis.

@nl

type

label

Randomized controlled study of ...... lopathy in advanced cirrhosis.

@ast

Randomized controlled study of ...... lopathy in advanced cirrhosis.

@en

Randomized controlled study of ...... lopathy in advanced cirrhosis.

@nl

prefLabel

Randomized controlled study of ...... lopathy in advanced cirrhosis.

@ast

Randomized controlled study of ...... lopathy in advanced cirrhosis.

@en

Randomized controlled study of ...... lopathy in advanced cirrhosis.

@nl

P1433

Q34708388-55B7FAA2-9291-42DF-B470-E744196248BB

P1476

Q34708388-3C73A673-85CF-4ABC-B6D4-2EBB2B46A2D2

P2093

Q34708388-34962C39-158B-43F4-A421-E155306B644F

Q34708388-8D5FAF2A-431A-4137-99EE-A7658637CAC2

Q34708388-AD782229-8B20-46C5-95CF-8BA2AA51B7CB

Q34708388-C29C00E7-DE65-4F15-AF16-448DC34D32F7

Q34708388-CDF0964F-826B-4CEB-A8E0-7B5A44D62CBF

Q34708388-D46A8B51-611B-4C19-BFE6-74733BA0D008

Q34708388-F51E3259-0274-440E-ACA3-58E8DCF443D8

Q34708388-FB88A125-F24F-4467-9C01-833B8C17991A

Q34708388-FF3CD179-0813-41DD-8D7C-C0D96006CD94

P304

Q34708388-9F369EA0-94E0-4465-A280-5E8F353AA057

P31

Q34708388-378AEFD6-65D7-461E-B272-AACC25B0D553

P356

Q34708388-3898140A-7890-4C07-B8C7-9FCFCAB21D85

P407

Q34708388-F8543949-9544-40B2-A09C-97136D8CCB89

P433

Q34708388-94D519FB-497B-469D-B675-626BF64D46A1

P478

Q34708388-0DB8E96F-2179-449D-8D57-F1253606982D

P50

Q34708388-DB329811-09AD-416D-8E25-0C25B980A300

P577

Q34708388-EFEEF05F-F664-43D5-980F-520CF689BE55

P5875

Q34708388-3F01CDC1-CFCD-4BCE-A4F3-31FD084A0168

P698

Q34708388-0345BEFF-55A4-4437-B120-CCB16C1AA7D2

P921

Q34708388-14F6001D-B6C4-46AD-9F59-EEB7F2B4758F

Q34708388-4A1E78AC-4C08-498A-B4E7-1747B8076B24

P356

P1433

P1476

Randomized controlled study of ...... alopathy in advanced cirrhosis

@en

P2093

Andres T Blei

http://www.w3.org/2001/XMLSchema#string

Brendan McGuire

http://www.w3.org/2001/XMLSchema#string

Flemming Tofteng

http://www.w3.org/2001/XMLSchema#string

Jan Stange

http://www.w3.org/2001/XMLSchema#string

Jeff Gornbein

http://www.w3.org/2001/XMLSchema#string

Patrick Lynch

http://www.w3.org/2001/XMLSchema#string

Ravindra Mehta

http://www.w3.org/2001/XMLSchema#string

Robert S Brown

http://www.w3.org/2001/XMLSchema#string

Tarek I Hassanein

http://www.w3.org/2001/XMLSchema#string

P304

1853-1862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.21930

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5870389

http://www.w3.org/2001/XMLSchema#string

P698

17975845

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis